Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions.

Cécile SoutyTitouan LaunayOlivier SteichenCécile ConteClément TurbelinMarianne SarazinAna-Maria VilcuLouise RossignolThierry BlanchonMaryse Lapeyre-MestreThomas Hanslik

Published in: European journal of clinical pharmacology (2020)

Exposures to potential DDIs in France are not uncommon with a high proportion resulting from a co-prescription by the same physician. Monitoring the prevalence of exposure to DDIs is needed to implement prevention measures. Administrative data enable this surveillance in large and representative cohorts.

Keyphrases

healthcare
risk factors
emergency department
cross sectional
machine learning
deep learning
risk assessment
climate change
long term care
data analysis
health information